Atlas Trials

A Study of the Safety, Tolerability, Pharmacokinetics and Food Effect After Single and Multiple Ascending Oral Doses

Clinical trial NCT05218434 · COMPLETED

Trial details

NCT number
NCT05218434
Sponsor
Artax Biopharma Inc
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Autoimmune Diseases
Start date
2021-11-17
Primary completion
2022-11-16
Enrollment
64

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.